RetinaCME

This activity is expired and is no longer available for CME credit.

EXPERT INTERVIEWCME

What Patients Are More Likely to Be Successfully Treated with Ocriplasmin?

Author(s)/Faculty: Carl D. Regillo, MD, FACS
Release Date: 9/13/2012Expiration Date: 9/12/2014
Credit Type: CME / ParticipationNumber of Credits: 0
Content Type: Provider:
Ocriplasmin for the Treatment of Patients with VMT and Full-Thickness Macular Hole: Subgroup Responder Analyses from the Phase III MIVI-TRUST Program...